🔗 Share this article

Treasury head Reeves has stated she is preparing "specific action to address household expense pressures" in the forthcoming financial statement.

During an interview with the BBC, she noted that curbing price rises is a collective duty of both the administration and the central bank.

The United Kingdom's inflation rate is expected to be the highest among the G7 advanced economies this year and the following year.

Potential Energy Bill Interventions

Reports indicate the government could take action to lower utility costs, for example by cutting the present 5% level of VAT charged on energy.

An additional option is to lower some of the policy costs currently included in bills.

Budgetary Limitations and Expert Expectations

The administration will obtain the latest report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much space there is for such actions.

The expectation from most experts is that Reeves will have to introduce tax increases or spending cuts in order to meet her self-imposed debt limits.

Earlier on the same day, estimates indicated there was a £22bn deficit for the chancellor to address, which is at the more modest range of projections.

"It is a collective job between the Bank of England and the administration to further reduce some of the causes of price increases," the Chancellor told reporters in Washington, at the conferences of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Concerns

While a great deal of the attention has been on probable tax increases, the Treasury chief said the latest figures from the OBR had not altered her commitment to election pledges not to raise rates on income tax, VAT or social security contributions.

She blamed an "unpredictable world" with increasing international and trade tensions for the fiscal revenue measures, probably to be directed on those "wealthiest."

International Trade Tensions

Addressing apprehensions about the United Kingdom's trade ties with the Asian nation she said: "Our security interests invariably come first."

Last week's statement by China to strengthen trade restrictions on critical minerals and other materials that are key for high-technology production led American leader the US President to threaten an additional 100% import tax on imports from the Asian country, increasing the prospect of an all-out commercial conflict between the two global powers.

The US Treasury Secretary labeled China's decision "economic coercion" and "a international production power grab."

Questioned on accepting the US offer to participate in its conflict with China, the Chancellor said she was "deeply worried" by China's actions and called on the Chinese government "to avoid restrictions and restrict access."

She said the decision was "bad for the global economy and causes further challenges."

"In my view there are sectors where we need to confront China, but there are also valuable prospects to trade with Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that balance correct."

The chancellor also confirmed she was cooperating with other major economies "regarding our own critical minerals approach, so that we are reduced dependence."

Health Service Drug Costs and Investment

Reeves also acknowledged that the price the NHS spends on medicines could increase as a result of current discussions with the Trump administration and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping investments in the United Kingdom, with several attributing the low prices they are receiving.

Last month, the Science Minister said the price the health service pays for medicines would have to rise to stop businesses and pharmaceutical investment leaving the UK.

The Chancellor stated to media: "It has been observed as a result of the payment system, that drug testing, innovative medicines have not been offered in the UK in the manner that they are in other European countries."

"We want to make sure that individuals receiving treatment from the National Health Service are able to obtain the top critical treatments in the globe. And so we are looking at this situation, and... looking to secure increased investment into the UK."